Chimera director granted 11,263 RSUs

Reilly Brian Patrick reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Reilly Brian Patrick reported acquisition or exercise transactions in this Form 4 filing.

Chimera Investment Corp director Brian Patrick Reilly received an equity grant of 11,263 restricted stock units (RSUs) of common stock. The RSUs vest on the earlier of the first anniversary of the June 11, 2026 grant date or the next annual stockholders meeting and will be settled entirely in Chimera common shares. After this award, Reilly holds 106,133 shares of common stock, reflecting a compensation-related grant rather than an open-market purchase.

Insider Trade Summary

Grant/Award: 11,263 shares

Grant/Award 1 txn

Insider Reilly Brian Patrick

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	11,263	$0.00	$0.00

Holdings After Transaction: Common Stock — 106,133 shares (Direct)

Footnotes (2)

1. F1. Represents shares of Chimera Investment Corporation ("Chimera") common stock underlying restricted stock units (RSUs). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 11, 2027, or, if earlier, (2) the date of the next annual stockholders meeting of the Chimera and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.
2. F2. Each RSU has the economic equivalent of one share of Chimera common stock.

Key Figures

RSUs granted: 11,263 RSUs Transaction price per share: $0.00 per share Shares held after transaction: 106,133 shares +2 more

5 metrics

RSUs granted 11,263 RSUs Restricted stock units of Chimera common stock granted to director

Transaction price per share $0.00 per share Equity award, not an open-market purchase

Shares held after transaction 106,133 shares Total Chimera common stock reported following the RSU grant

Vesting deadline June 11, 2027 Latest vesting date; earlier vesting at next annual stockholders meeting

RSU-to-share ratio 1 RSU : 1 share Each RSU has the economic equivalent of one Chimera common share

Key Terms

restricted stock units (RSUs), vest, economic equivalent, grant, award, or other acquisition

4 terms

restricted stock units (RSUs) financial

"Represents shares of Chimera Investment Corporation common stock underlying restricted stock units (RSUs)."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

vest financial

"The RSUs are scheduled to vest on the earlier of the first anniversary of the grant date or the date of the next annual stockholders meeting."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

economic equivalent financial

"Each RSU has the economic equivalent of one share of Chimera common stock."

grant, award, or other acquisition financial

"Transaction code A is described as Grant, award, or other acquisition."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Chimera Investment Corp (CIM) report for Brian Patrick Reilly?

Chimera Investment Corp reported that director Brian Patrick Reilly received a grant of 11,263 restricted stock units of common stock. This is a compensation-related equity award rather than an open-market trade, aligning the director’s interests with shareholders through additional stock-based incentives.

How many RSUs did Brian Patrick Reilly receive from Chimera Investment Corp (CIM)?

Brian Patrick Reilly received 11,263 restricted stock units of Chimera common stock. Each RSU has the economic equivalent of one share, meaning the award represents 11,263 potential shares that will be delivered upon vesting, subject to the stated vesting schedule and settlement terms.

What is the vesting schedule for Brian Patrick Reilly’s RSUs at Chimera (CIM)?

The RSUs are scheduled to vest on the earlier of the first anniversary of the June 11, 2026 grant date or the date of Chimera’s next annual stockholders meeting. Once vested, they will be settled 100% in shares of Chimera common stock according to the award terms.

How many Chimera (CIM) shares does Brian Patrick Reilly hold after this Form 4 transaction?

Following the RSU grant, Brian Patrick Reilly is reported as holding 106,133 shares of Chimera common stock. This total reflects his direct ownership position after the award and shows the scale of his equity stake relative to the 11,263-unit grant disclosed.

Was Brian Patrick Reilly’s Chimera (CIM) RSU grant an open-market purchase?

No. The Form 4 describes the transaction with code A as a grant or award of restricted stock units. The RSUs carry a zero transaction price and are part of director compensation, not a voluntary open-market purchase of Chimera common stock on an exchange.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/15/2026 - 04:35 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reilly Brian Patrick

(Last) (First) (Middle)

C/O CHIMERA INVESTMENT CORPORATION

ONE ROCKEFELLER PLAZA, 32ND FLOOR

(Street)

NEW YORK NEW YORK 10020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHIMERA INVESTMENT CORP [ CIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/11/2026		A		11,263(1)	A	$0(2)	106,133	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of Chimera Investment Corporation ("Chimera") common stock underlying restricted stock units (RSUs). The RSUs are scheduled to vest on the earlier of (1) the first anniversary of the grant date, June 11, 2027, or, if earlier, (2) the date of the next annual stockholders meeting of the Chimera and shall be settled 100% in shares of Chimera common stock. The reporting person does not intend to report the vesting of the RSUs nor the delivery of the shares of common stock.

2. Each RSU has the economic equivalent of one share of Chimera common stock.

Remarks:

	/s/ Brian Patrick Reilly	06/15/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)